PRESS RELEASE published on 07/01/2024 at 14:00, 1 year 10 months ago Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024 Catheter Precision, Inc. reports 15% quarter-over-quarter growth with initial sales of LockeT recorded, generating total revenue of $94,840 for Q2 ending June 30, 2024 Revenue Growth Catheter Precision, Inc. Cardiac Electrophysiology LockeT Sales VIVO Products
PRESS RELEASE published on 07/01/2024 at 13:48, 1 year 10 months ago Issue of Equity M&G Credit Income Investment Trust plc announces the issue of equity with 50,000 ordinary shares sold at a premium, increasing the total number of shares Shareholders Ordinary Shares Net Asset Value M&G Credit Income Investment Trust Plc Equity Issue
PRESS RELEASE published on 07/01/2024 at 13:43, 1 year 10 months ago CRCAM Brie Picardie – déclaration hebdomadaire – Rachats réalisés dans les conditions de l'article 5 du Règlement MAR Caisse Régionale de Crédit Agricole Mutuel Brie Picardie réalise des rachats conformément au Règlement MAR, avec une approche agrégée et détaillée par jour et par transaction Règlement MAR Rachats Caisse Régionale De Crédit Agricole Mutuel Brie Picardie Approche Agrégée Approche Détaillée
PRESS RELEASE published on 07/01/2024 at 13:15, 1 year 10 months ago Edison issues report on Target Healthcare REIT (THRL) Edison Investment Research Limited releases a report on Target Healthcare REIT (THRL). The report is available for free download on Edison's website. For more information, contact enquiries@edisongroup.com Edison Investment Research Limited Financial Analysis Target Healthcare REIT Report Investment Advice
PRESS RELEASE published on 07/01/2024 at 13:00, 1 year 10 months ago Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals Supervisory Board Radiopharmaceuticals Pentixapharm AG Marcus Quinkler Endocrinologist
PRESS RELEASE published on 07/01/2024 at 12:48, 1 year 10 months ago Total Voting Rights M&G Credit Income Investment Trust plc announces total voting rights as at 30 June 2024. Share capital: 141,944,239 Ordinary Shares. Excludes 2,801,532 shares held in treasury Share Capital Ordinary Shares M&G Credit Income Investment Trust Plc Total Voting Rights Financial Conduct Authority
PRESS RELEASE published on 07/01/2024 at 12:30, 1 year 10 months ago US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians Zomedica Corp.'s PulseVet Shock Wave Device named Official Shock Wave Therapy Supplier of US Equestrian team veterinarians for major international team events. Partnership with USEF to enhance equine athlete care Zomedica Corp. Veterinary Health US Equestrian PulseVet Shock Wave Device Equine Athletes
PRESS RELEASE published on 07/01/2024 at 12:30, 1 year 10 months ago NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections NanoViricides, Inc. elaborates on its lead broad-spectrum antiviral drug candidate NV-387, poised to revolutionize viral disease treatment. Plans include Phase II studies for RSV and market expansion NV-387 NanoViricides Inc. Antiviral Drug Viral Diseases Phase II Studies
PRESS RELEASE published on 07/01/2024 at 12:10, 1 year 10 months ago Report de l'approbation des comptes 2023 au 31 octobre 2024 au plus tard GAUSSIN obtient un délai pour arrêter et publier ses comptes 2023 accordé par le Tribunal de commerce de Vesoul. Euronext transfère temporairement les actions sur le compartiment 'Penalty Bench' Euronext Tribunal De Commerce Comptes 2023 GAUSSIN Penalty Bench
PRESS RELEASE published on 07/01/2024 at 12:10, 1 year 10 months ago Report de l'approbation des comptes 2023 au 31 octobre 2024 au plus tard GAUSSIN annonce le report de l'approbation des comptes 2023 au 31 octobre 2024 suite a une situation exceptionnelle. Euronext transfère temporairement ses actions dans le compartiment 'Penalty Bench' Euronext Report Comptes 2023 GAUSSIN Penalty Bench
Published on 05/13/2026 at 19:25, 14 minutes ago Bolt Metals Executes Option to Acquire The High-Grade Floralia Iron Project, Prepares for Maiden Drill Program at Northwind
Published on 05/13/2026 at 15:30, 4 hours 9 minutes ago All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 4 hours 34 minutes ago Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 4 hours 39 minutes ago ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 4 hours 39 minutes ago Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
Published on 05/13/2026 at 19:28, 10 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 19:14, 24 minutes ago EQS-Adhoc: Oldenburgische Landesbank AG: Oldenburgische Landesbank AG intends to call its Additional Tier 1 bond
Published on 05/13/2026 at 18:15, 1 hour 24 minutes ago Africa Energy Forum 2026: Building Africa's Industrialised Future
Published on 05/13/2026 at 18:15, 1 hour 24 minutes ago Africa Energy Forum 2026 : Construire l’avenir industrialisé de l’Afrique
Published on 05/13/2026 at 18:02, 1 hour 37 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 hour 39 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 1 hour 54 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.